News Maxor’s Response to the Coronavirus Mar 13, 2020 Clinical News, COVID-19, Maxor Pharmacy Management, Maxor Specialty, Maxor340B, MaxorPlus This memo details Maxor’s perspective on the current COVID-19 situation and contingency planning across Maxor’s various business lines, including PBM, retail/hospital pharmacy, and specialty pharmacy. READ MORE Related News Maxor Chief Pharmacy Officer, Michael Einodshofer, officially becomes Chairman of the Board during NASP 2020 Industry News, Maxor, Maxor Specialty, MaxorPlus, Press Releases MaxorPlus Webinar – Specialty Pipeline and Management Solutions Available Clinical News, Maxor, Maxor Specialty, MaxorPlus MaxorPlus Eases Access to Rx Benefits, Improves Adherence, Lowers Costs with Unique Push Technology MaxorPlus See more news. Categories Clinical News COVID-19 Industry News Maxor Maxor Pharmacy Management Maxor Specialty Maxor340B MaxorPlus Press Releases
Maxor Chief Pharmacy Officer, Michael Einodshofer, officially becomes Chairman of the Board during NASP 2020 Industry News, Maxor, Maxor Specialty, MaxorPlus, Press Releases
MaxorPlus Webinar – Specialty Pipeline and Management Solutions Available Clinical News, Maxor, Maxor Specialty, MaxorPlus
MaxorPlus Eases Access to Rx Benefits, Improves Adherence, Lowers Costs with Unique Push Technology MaxorPlus
